Claudiu T. Supuran
Claudiu T. Supuran
Verified email at unifi.it
TitleCited byYear
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
CT Supuran
Nature reviews Drug discovery 7 (2), 168, 2008
21842008
Carbonic anhydrase inhibitors
CT Supuran, A Scozzafava, A Casini
Medicinal research reviews 23 (2), 146-189, 2003
1708*2003
Interfering with pH regulation in tumours as a therapeutic strategy
D Neri, CT Supuran
Nature reviews Drug discovery 10 (10), 767, 2011
9822011
Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?
V Alterio, A Di Fiore, K D’Ambrosio, CT Supuran, G De Simone
Chemical reviews 112 (8), 4421-4468, 2012
6832012
Review article
S Pastorekova, S Parkkila, J Pastorek, CT Supuran
Journal of enzyme inhibition and medicinal chemistry 19 (3), 199-229, 2004
6402004
Hypoxia activates the capacity of tumor‐associated carbonic anhydrase IX to acidify extracellular pH
E Švastová, A Hulı́ková, M Rafajová, M Zat'ovičová, A Gibadulinová, ...
FEBS letters 577 (3), 439-445, 2004
6162004
Anticancer and antiviral sulfonamides
A Scozzafava, T Owa, A Mastrolorenzo, CT Supuran
Current medicinal chemistry 10 (11), 925-953, 2003
5682003
Carbonic anhydrase inhibitors and their therapeutic potential
CT Supuran, A Scozzafava
Expert Opinion on Therapeutic Patents 10 (5), 575-600, 2000
5142000
Carbonic anhydrases as targets for medicinal chemistry
CT Supuran, A Scozzafava
Bioorganic & medicinal chemistry 15 (13), 4336-4350, 2007
5052007
Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors
Y Lou, PC McDonald, A Oloumi, S Chia, C Ostlund, A Ahmadi, A Kyle, ...
Cancer research 71 (9), 3364-3376, 2011
4422011
Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition
A Weber, A Casini, A Heine, D Kuhn, CT Supuran, A Scozzafava, G Klebe
Journal of medicinal chemistry 47 (3), 550-557, 2004
4352004
Structure-based drug discovery of carbonic anhydrase inhibitors
CT Supuran
Journal of enzyme inhibition and medicinal chemistry 27 (6), 759-772, 2012
4202012
Carbonic anhydrases-an overview
CT Supuran
Current pharmaceutical design 14 (7), 603-614, 2008
4072008
Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX
V Alterio, M Hilvo, A Di Fiore, CT Supuran, P Pan, S Parkkila, A Scaloni, ...
Proceedings of the National Academy of Sciences 106 (38), 16233-16238, 2009
3672009
Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents
CT Supuran, A Casini, A Scozzafava
Medicinal Research Reviews 23 (5), 535-558, 2003
3662003
Targeting tumor-associated carbonic anhydrase IX in cancer therapy
A Thiry, JM Dogne, B Masereel, CT Supuran
Trends in pharmacological sciences 27 (11), 566-573, 2006
3592006
Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors
A Maresca, C Temperini, H Vu, NB Pham, SA Poulsen, A Scozzafava, ...
Journal of the American Chemical Society 131 (8), 3057-3062, 2009
3492009
Adverse cardiovascular effects of the coxibs
JM Dogné, CT Supuran, D Pratico
Journal of Medicinal Chemistry 48 (7), 2251-2257, 2005
3282005
How many carbonic anhydrase inhibition mechanisms exist?
CT Supuran
Journal of enzyme inhibition and medicinal chemistry 31 (3), 345-360, 2016
3202016
Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis
F Pacchiano, F Carta, PC McDonald, Y Lou, D Vullo, A Scozzafava, ...
Journal of medicinal chemistry 54 (6), 1896-1902, 2011
3062011
The system can't perform the operation now. Try again later.
Articles 1–20